单搏右室-肺动脉耦联与HeartMate 3左室辅助装置患者的残余心力衰竭
研究纳入2018至2022年植入HeartMate 3左室辅助装置的70例成人患者,在超声与侵入性装置优化后行出院前右心导管检查,用单搏法从高保真压力波形推导右室收缩末期弹性、肺动脉有效动脉弹性及两者比值。结果显示患者存在右室-肺动脉失耦联,较高的肺动脉有效弹性与较低心输出量及高剂量利尿剂使用相关,而耦联受损是唯一与3个月6分钟步行距离降低相关的水流动力学参数。
要点
- 单搏法右室-肺动脉弹性指标可识别装置优化后仍存在的残余心衰表型。
- 肺动脉有效弹性升高与出院心输出量降低及高剂量门诊利尿剂需求独立相关。
- 右室-肺动脉耦联受损是唯一与3个月6分钟步行距离降低相关的血流动力学参数。
核心结论
- 单搏右室-肺动脉弹性指标可识别临床已优化的HeartMate 3患者中标准右心指标未能捕捉的残余心衰表型。
- 若经前瞻性验证,将右室收缩末期弹性、肺动脉有效弹性(「血流梗阻」)与两者比值(「能量低效」)纳入出院前评估,可能有助于细化风险分层并指导装置与肺血管干预。
研究设计与样本
- 研究为单中心队列,纳入2018至2022年植入HeartMate 3左室辅助装置的70例成人患者。
- 患者在超声与侵入性左室辅助装置优化后行出院前右心导管检查,并以单搏法从高保真压力波形推导右室收缩末期弹性、肺动脉有效动脉弹性及两者比值。
- 采用多变量回归评估上述指标与残余心衰替代指标(出院心输出量、高剂量门诊利尿剂需求、3个月6分钟步行距离)的关联。
主要发现
- 尽管左室辅助装置支持已优化,患者右室收缩末期弹性为0.40 ± 0.19 mmHg/ml,肺动脉有效动脉弹性升高为0.54 ± 0.21 mmHg/ml,两者比值为0.78 ± 0.36,符合右室-肺动脉失耦联。
- 较高的肺动脉有效动脉弹性独立关联较低心输出量与较高高剂量利尿剂使用可能性。
- 右室-肺动脉耦联受损(较低比值)是唯一与6分钟步行距离降低相关的血流动力学参数。
- 传统右心指标如肺动脉搏动指数与中心静脉压/楔压比值与上述结局无关联。
关键数值与推荐
- 右室收缩末期弹性0.40 ± 0.19 mmHg/ml、肺动脉有效动脉弹性0.54 ± 0.21 mmHg/ml、两者比值0.78 ± 0.36(n=70,HeartMate 3患者出院前右心导管)。
- 较高的肺动脉有效动脉弹性独立关联较低心输出量与较高高剂量利尿剂使用可能性(多变量回归)。
- 较低的右室-肺动脉耦联比值是唯一与3个月6分钟步行距离降低相关的血流动力学参数(多变量回归)。
- 肺动脉搏动指数与中心静脉压/楔压比值与结局无关联。
临床怎么用
- 对HeartMate 3患者可在出院前右心导管中尝试单搏法测算右室收缩末期弹性、肺动脉有效动脉弹性及比值,以补充传统右心指标识别残余心衰风险。
- 肺动脉有效动脉弹性升高提示「血流梗阻」表型,或可指导利尿剂管理与肺血管干预的个体化决策,但需前瞻性验证。
局限性
- 样本量70例,为单中心队列,结果需前瞻性验证。
- 单搏法弹性指标依赖高保真压力波形,测量条件与可重复性可能影响外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contemporary left ventricular assist devices (LVADs) improve survival, yet residual heart failure (HF) remains despite optimized device support. The extent to which right ventricular (RV)-pulmonary artery (PA) interaction, measured by single-beat elastance-based indices, identifies residual risk is unknown. METHODS: We studied 70 adults implanted with HeartMate3 LVADs (2018-2022) who underwent pre-discharge right heart catheterization after echocardiographic and invasive LVAD optimization. Using a single-beat method, RV end-systolic elastance (Ees), PA effective arterial elastance (Ea), and the Ees:Ea ratio (RV-PA coupling) were derived from high-fidelity pressure waveforms. Associations between these indices and surrogates of residual HF (cardiac output [CO] at discharge, need for high-dose outpatient diuretics, and 3-month 6-minute walking distance [6MWD]) were evaluated using multivariable regressions. RESULTS: Despite optimized LVAD support, patients demonstrated preserved RV Ees (0.40 ± 0.19mmHg/ml), elevated PA Ea (0.54 ± 0.21 mmHg/ml) and reduced Ees:Ea ratio (0.78 ± 0.36), consistent with RV-PA uncoupling. Higher PA Ea independently associated with lower CO and greater likelihood of high-dose diuretic use, while impaired RV-PA coupling (lower Ees:Ea) was the only hemodynamic parameter associated with reduced 6MWD. Traditional RV indices, including PAPi and CVP-to-wedge ratio, were not associated with outcomes. CONCLUSION: Single-beat RV-PA elastance metrics identify residual HF phenotypes in clinically optimized HM3 recipients not captured by standard right-sided indices. If prospectively validated, incorporating RV Ees, PA Ea ("flow obstruction") and Ees:Ea ("energy inefficiency") into pre-discharge assessment may be used to refine risk stratification and inform device-directed and pulmonary vascular interventions during LVAD.
引用
- Castagna F, Faini A, Parati G, et al. Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. J Heart Lung Transplant. 2026. PMID: 41949525. doi:10.1016/j.healun.2026.02.1661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。